Erratum: Funding Crunch Forces Stem Cell Company to Abandon Therapies
Nature Biotechnology - United Kingdom
doi 10.1038/nbt1207-1488a
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2007
Authors
Publisher
Springer Science and Business Media LLC